姚国泰, 黎 娟, 陈 励. 秋水仙碱在心血管疾病方面的研究进展[J]. 心脏杂志, 2016, 28(4): 483-487.
    引用本文: 姚国泰, 黎 娟, 陈 励. 秋水仙碱在心血管疾病方面的研究进展[J]. 心脏杂志, 2016, 28(4): 483-487.
    Advances in research of colchicine in cardiovascular diseases[J]. Chinese Heart Journal, 2016, 28(4): 483-487.
    Citation: Advances in research of colchicine in cardiovascular diseases[J]. Chinese Heart Journal, 2016, 28(4): 483-487.

    秋水仙碱在心血管疾病方面的研究进展

    Advances in research of colchicine in cardiovascular diseases

    • 摘要: 秋水仙碱为一种脂溶性有较长半衰期和较高生物利用率的生物碱,由于具有抗炎作用,最初被应用于治疗预防急性痛风和预防自身炎症性疾病的发作。它主要的作用机理是通过结合微管蛋白抑制微管的聚合,从而干扰白细胞及细胞因子的功能来发挥抗炎作用。随着人们对它的药理和毒理机制研究的不断深入,发现它特有的抗炎性在心包炎、冠脉疾病、房颤以及心衰等心血管疾病的防治中可发挥着重要的作用,现就将秋水仙碱在心血管系统的研究进展做一综述。

       

      Abstract: Colchicine, a lipid-soluble alkaloid with long terminal half-life and high bioavailability, is initially used to treat and prevent acute gout and to prevent autoinflammatory diseases due to its anti-inflammatory property. Its main mechanism of action is to inhibit microtubule polymerization by binding to tubulin, thus affecting the functions of leucocytes and cytokines. With better understanding of pharmacologic properties and toxicity of colchicine, colchicine is found to be beneficial in the prevention and treatment of cardiovascular diseases because of its unique anti-inflammatory property. Previous trials and studies have shown that colchicine plays a significant role in the treatment of cardiovascular diseases such as pericarditis, coronary artery disease, atrial fibrillation and heart failure. In this review, we briefly review the role of colchicine in the prevention and treatment of cardiovascular diseases.

       

    /

    返回文章
    返回